These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36308299)

  • 21. Efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double-blind, phase 3 trial.
    Kaku K; Isaka H; Sakatani T; Toyoshima J
    Diabetes Obes Metab; 2019 Oct; 21(10):2284-2293. PubMed ID: 31173455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between circulating leukocyte subtype counts and carotid intima-media thickness in Japanese subjects with type 2 diabetes.
    Matsumura T; Taketa K; Motoshima H; Senokuchi T; Ishii N; Kinoshita H; Fukuda K; Yamada S; Kukidome D; Kondo T; Hisada A; Katoh T; Shimoda S; Nishikawa T; Araki E
    Cardiovasc Diabetol; 2013 Dec; 12():177. PubMed ID: 24373412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin.
    Kaku K; Kadowaki T; Seino Y; Okamoto T; Shirakawa M; Sato A; O'Neill EA; Engel SS; Kaufman KD
    Diabetes Obes Metab; 2021 Sep; 23(9):2099-2108. PubMed ID: 34033212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study.
    Kashiwagi A; Kazuta K; Goto K; Yoshida S; Ueyama E; Utsuno A
    Diabetes Obes Metab; 2015 Mar; 17(3):304-8. PubMed ID: 24919820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sitagliptin on Carotid Intima-Media Thickness in Type 2 Diabetes Mellitus Patients and Anemia: A Subgroup Analysis of the PROLOGUE Study.
    Lu Z; Ma G; Chen L
    Mediators Inflamm; 2020; 2020():8143835. PubMed ID: 32454794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes.
    Taya N; Katakami N; Mita T; Okada Y; Wakasugi S; Yoshii H; Shiraiwa T; Otsuka A; Umayahara Y; Ryomoto K; Hatazaki M; Yasuda T; Yamamoto T; Gosho M; Shimomura I; Watada H
    Cardiovasc Diabetol; 2021 May; 20(1):95. PubMed ID: 33947398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a 90 g/day low-carbohydrate diet on glycaemic control, small, dense low-density lipoprotein and carotid intima-media thickness in type 2 diabetic patients: An 18-month randomised controlled trial.
    Chen CY; Huang WS; Chen HC; Chang CH; Lee LT; Chen HS; Kang YD; Chie WC; Jan CF; Wang WD; Tsai JS
    PLoS One; 2020; 15(10):e0240158. PubMed ID: 33017456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fenofibrate effects on carotid artery intima-media thickness in adults with type 2 diabetes mellitus: A FIELD substudy.
    Harmer JA; Keech AC; Veillard AS; Skilton MR; Watts GF; Celermajer DS;
    Diabetes Res Clin Pract; 2018 Jul; 141():156-167. PubMed ID: 29763709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.
    Barbieri M; Rizzo MR; Marfella R; Boccardi V; Esposito A; Pansini A; Paolisso G
    Atherosclerosis; 2013 Apr; 227(2):349-54. PubMed ID: 23375680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes.
    Larsen JR; Brekke M; Bergengen L; Sandvik L; Arnesen H; Hanssen KF; Dahl-Jorgensen K
    Diabetologia; 2005 Apr; 48(4):776-9. PubMed ID: 15759107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the long-term ASP1941 safety evaluation in patients with type 2 diabetes with renal impairment (LANTERN) study.
    Kashiwagi A; Takahashi H; Ishikawa H; Yoshida S; Kazuta K; Utsuno A; Ueyama E
    Diabetes Obes Metab; 2015 Feb; 17(2):152-60. PubMed ID: 25347938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study.
    Tanaka A; Yoshida H; Nanasato M; Oyama JI; Ishizu T; Ajioka M; Ishiki R; Saito M; Shibata Y; Kaku K; Maemura K; Higashi Y; Inoue T; Murohara T; Node K
    Int J Cardiol; 2018 Nov; 271():331-335. PubMed ID: 29803341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial.
    Ito D; Shimizu S; Inoue K; Saito D; Yanagisawa M; Inukai K; Akiyama Y; Morimoto Y; Noda M; Shimada A
    Diabetes Care; 2017 Oct; 40(10):1364-1372. PubMed ID: 28751548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus.
    Shestakova MV; Wilding JPH; Wilpshaar W; Tretter R; Orlova VL; Verbovoy AF
    Diabetes Res Clin Pract; 2018 Dec; 146():240-250. PubMed ID: 30391333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
    Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
    Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic indicators of persistent carotid intima-media thickness increase in postpartum period in a population of normotensive women with gestational diabetes mellitus.
    Sonaglioni A; Nicolosi GL; Esposito V; Bianchi S; Lombardo M
    Eur J Obstet Gynecol Reprod Biol; 2022 Feb; 269():47-54. PubMed ID: 34968874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose-finding study.
    Wilding JP; Ferrannini E; Fonseca VA; Wilpshaar W; Dhanjal P; Houzer A
    Diabetes Obes Metab; 2013 May; 15(5):403-9. PubMed ID: 23163880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The estimated glomerular filtration rate is associated with subclinical atherosclerosis, independently of albuminuria, in patients with type 2 diabetes.
    Lu B; Wan J; Yang Y; Li Y; Hu R
    Int Angiol; 2013 Oct; 32(5):532-9. PubMed ID: 23903314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study.
    Rizvi AA; Patti AM; Giglio RV; Nikolic D; Amato A; Al-Busaidi N; Al-Rasadi K; Soresi M; Banach M; Montalto G; Rizzo M
    Expert Opin Biol Ther; 2015; 15(10):1391-7. PubMed ID: 26195184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).
    Koshizaka M; Ishikawa K; Ishibashi R; Maezawa Y; Sakamoto K; Uchida D; Nakamura S; Yamaga M; Yokoh H; Kobayashi A; Onishi S; Kobayashi K; Ogino J; Hashimoto N; Tokuyama H; Shimada F; Ohara E; Ishikawa T; Shoji M; Ide S; Ide K; Baba Y; Hattori A; Kitamoto T; Horikoshi T; Shimofusa R; Takahashi S; Nagashima K; Sato Y; Takemoto M; Newby LK; Yokote K;
    Diabetes Obes Metab; 2019 Aug; 21(8):1990-1995. PubMed ID: 30993861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.